KDM5D and cancer: On the other hand, transcript levels of KDM5D were significantly decreased in 14 types of cancer, including PDAC, adrenocortical carcinoma (ACC) and colonic adenocarcinoma (COAD), compared to paraneoplastic or normal tissues (Supplementary Fig. 1A–D).